Two Dose Version of Johnson & Johnson Shot 94% Effective Against COVID-19, Study Finds
- Aryaman Sinha
- Sep 22, 2021
- 1 min read

A two-dose version of Johnson & Johnson's coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday -- making a two-dose regimen of J&J's Janssen vaccine comparable to a two-dose regimen of Moderna's or Pfizer's. Awesome!
Photo Credit: Possessed Photography
Comments